Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patients

Molecular Medicine Reports

Volumn 6, Issue 5, 2012, Pages 937-943

  Masuda, Ryota ^a   Kijima, Hiroshi ^b   Imamura, Naoko ^a   Aruga, Naohiro ^a   Nakamura, Yusuke ^a   Masuda, Daisuke ^a   Takeichi, Haruka ^a   Kato, Nobusuke ^a   Nakagawa, Tomoki ^a   Tanaka, Makiko ^a   Inokuchi, Sadaki ^a   Iwazaki, Masayuki ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Lung cancer; Patient prognosis; Squamous cell carcinoma; Tumor budding

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INFILTRATION; CANCER INVASION; CANCER MORTALITY; CANCER PROGNOSIS; CELL BUDDING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; TUMOR BUDDING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 84866436572     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1048     Document Type: Article

References (30)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Beadsmoore CJ and Screation NJ: Classification, staging and prognosis of lung cancer. Eur J Radiol 45: 8-17, 2003. (Pubitemid 36024163)
3. Goldstraw P, Crowley J, Chansky KJ, et al: The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. Thorac Oncol 2: 706-714, 2007. (Pubitemid 47357522)
4. Marchesani W: Über den primären Bronchialkrebs. Frankf Z Path 30: 158-190, 1924 (In German).
5. Kayser K, Bauer A, David H and Kayser G: Historical aspects of pulmonary pathology with specific emphasis on ancient reports. Electronic Journal of Pathology and Histology 9.2: 32-37, 2003.
6. Travis WD, Brambilla E, Müller-Hermelin HK and Harris CC (eds): World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, Lyon, 2004.
7. Hong J, Kyung SY, Lee SP, et al: Pemetrexed versus gefitinib versus erlotinib in previously treated patients with non-small cell lung cancer. Korean J Intern Med 25: 294-300, 2010.
8. Rossi A, Ricciardi S, Maione P, de Marinis F and Gridelli C: Pemetrexed in the treatment of advanced non-squamous lung cancer. Lung Cancer 66: 141-149, 2009.
9. Sandler A, Gray R, Perry MC, et al: Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355: 2542-2550, 2006. (Pubitemid 44917502)
10. Reck M, von Pawel J, Zatloukal P, et al: Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil. J Clin Oncol 27: 1227-1234, 2009.
11. Rosell R, Perez-Roca L, Sanchez JJ, et al: Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression. PLoS One 4: e5133, 2009.
12. Okada K, Kijima H, Imaizumi T, et al: Wall-invasion pattern correlates with survival of patients with gallbladder adenocarcinoma. Anticancer Res 29: 685-691, 2009.
13. Song KY, Hur H, Jung CK, et al: Impact of tumor infiltration pattern into the surrounding tissue on prognosis of the subserosal gastric cancer (pT2b). Eur J Surg Oncol 36: 563-567, 2010.
14. Kong KY, Park JY, Kim DY, et al: Prognostic significance of stromal microinvasion in the intestinal type of ovarian mucinous adenocarcinoma. Ann Surg Oncol 18: 3462-3468, 2011.
15. Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K and Morimatsu M: An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 63: 539-543, 1989. (Pubitemid 19038471)
16. Ueno H, Murphy J, Jass JR, Mochizuki H and Talbot IC: Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40: 127-132, 2002. (Pubitemid 34122114)
17. Nakanishi Y, Ohara M, Doumen H, Kimura N, Ishidate T and Kondo S: Correlation between tumor budding and post-resection prognosis in patients with invasive squamous cell carcinoma of the thoracic esophagus. World J Surg 35: 349-356, 2011.
18. Ohike N, Coban I, Kim GE, et al: Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas. Am J Surg Pathol 34: 1417-1424, 2010.
19. Wang C, Huang H, Huang Z, et al: Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med 40: 545-551, 2011.
20. Sarioglu S, Acara C, Akman FC, et al: Tumor budding as a prognostic marker in laryngeal carcinoma. Pathol Res Pract 206: 88-92, 2010.
21. Yamaguchi Y, Ishii G, Kojima M, et al: Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness. J Thorac Oncol 5: 1361-1368, 2010.
22. Sobin LH, Gospodarowicz MK and Wittekind C (eds): TNM Classification of Malignant Tumors. 7th edition. Wiley, Hoboken, NJ, 2009.
23. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1: 10-24, 1998.
24. Maehara Y, Oshiro T, Adachi Y, Ohno S, Akazawa K and Sugimachi K: Growth pattern and prognosis of gastric cancer invading the subserosa. J Surg Oncol 55: 203-208, 1994. (Pubitemid 24143287)
25. Haraguchi M, Yamamoto M, Saito A, et al: Prognostic value of depth and pattern of stomach wall invasion in patients with an advanced gastric carcinoma. Semin Surg Oncol 10: 125-129, 1994. (Pubitemid 24181268)
26. Hase K, Shatney C, Johnson D, Trollope M and Vierra M: Prognostic value of tumor 'budding' in patients with colorectal cancer. Dis Colon Rectum 36: 627-635, 1993. (Pubitemid 23206317)
27. Maeshima AM, Maeshima A, Asamura H and Matsuno Y: Histologic prognostic factors for small-sized squamous cell carcinomas of the peripheral lung. Lung Cancer 52: 53-58, 2006. (Pubitemid 43340199)
28. Prall F: Tumour budding in colorectal carcinoma. Histopathology 50: 151-162, 2007.
29. Shinto E, Tsuda H, Ueno H, et al: Prognostic implication of laminin-5 gamma 2 chain expression in the invasive front of colorectal cancers, disclosed by area-specific four-point tissue microaarays. Lab Invest 85: 257-266, 2005. (Pubitemid 40208929)
30. Moriya Y, Niki T, Yamada T, Matsuno T, Kondo H and Hirohashi S: Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. An immunohistochemical analysis of 102 cases. Cancer 91: 1129-1141, 2001. (Pubitemid 32295418)